In searching for a basolateral membrane water trans-porter in rat kidney with homology to channel formingintegral protein (CHIP28), water channel-collecting duct (WCH-CD), and mercurial-insensitive water chan-nel (MIWC), we cloned a new member of the major in-trinsic protein family (GLIP, -cero1 Intrinsic B o -tein). GLIP cDNA had an 865-base pair open reading frame encoding a 30.6-kDa protein with 19-23% amino acid identity to the water channels and 36% identity to the bacterial glycerol facilitator GlpF. Northern blot analysis showed a 6.6-kilobase mFWA encoding GLIP in kidney, brain, and lung; RT-PCWSouthern blot analysis indicated expression of GLIP in kidney, brain, lung, eye, colon, stomach, and skeletal muscle, but not in heart, liver, and spleen. In situ hybridization in rat kidney showed GLIP mRNA expression in medullary collecting duct. Immunofluorescence with a peptide-derived poly-clonal antibody showed GLIP protein expression in ba-solateral membrane of kidney collecting duct principal cells and brain meningeal cells. Functional measure-ments in Xenopus oocytes expressing GLIP cRNA showed a>2O-fold increase in [SHlglycerol uptake com-pared with water-iqjected oocytes; glycerol uptake was inhibited 88% by diisothiocyanodisdfonic stilbene (0.2mm) and 36% by phloretin (0.25mm). GLIP did not func-tion as a transporter for water, urea, inositol, glucose, lactate, and monovalent ions. Glycerol uptake in oocytes expressing CHIP28 and MIWC was not different from that in water-injected controls. GLIP represents the first mammalian water channel homolog that selectively transports a solute other than water. The physiological substrate(s) and role(s) of GLIP remain to be elucidated.

Fluid transport is a major function of the gastrointestinal (GI) tract with more than 9 litres of fluid being absorbed or secreted across epithelia in human salivary gland, stomach, the hepatobiliary tract, pancreas, small intestine and colon. This review evaluates the evidence that aquaporin-type water channels are involved in GI fluid transport. The aquaporins are a family of small (•30 kDa) integral membrane proteins that function as water channels. At least seven aquaporins are expressed in various tissues in the GI tract: AQP1 in intrahepatic cholangiocytes, AQP4 in gastric parietal cells, AQP3 and AQP4 in colonic surface epithelium, AQP5 in salivary gland, AQP7 in small intestine, AQP8 in liver, pancreas and colon, and AQP9 in liver. There are functional data suggesting that some GI cell types expressing aquaporins have high or regulated water permeability; however, there has been no direct evidence for a role of aquaporins in GI physiology. Recently, transgenic mice have been generated with selective deletions of various aquaporins. Preliminary evaluation of GI function suggests a role for AQP1 in dietary fat processing and AQP4 in colonic fluid absorption. Further study of aquaporin function in the GI tract should provide new insights into normal GI physiology and disease mechanisms, and may yield novel therapies to regulate fluid movement in GI diseases.

Ma, Tonghui, Sujatha Jayaraman, Kasper S. Wang, Yuanlin Song, Baoxue Yang, Jiang Li, J. Augusto Bastidas, and A. S. Verkman. Defective dietary fat processing in transgenic mice lacking aquaporin-1 water channels. Am J Physiol Cell Physiol 280: C126-C134, 2001.-Immunocytochemistry showed expression of aquaporin-1 (AQP1) water channels at sites involved in dietary fat processing, including intrahepatic cholangiocytes, gallbladder, pancreatic microvascular endothelium, and intestinal lacteals. To determine whether AQP1 has a role in dietary fat digestion and/or absorption, mice were placed on a diet that contained 50% fat. Whereas wild-type mice (3-3.5 wk of age, 10-12g) gained 49

Deletion of Phe-508 (F508) is the most common mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) causing cystic fibrosis. △F508-CFTR has defects in both channel gating and endoplasmic reticulum-to-plasma membrane processing. We identified six novel classes of high affinity potentiators of defective F508-CFTR Cl-channel gating by screening 100,000 diverse small molecules. Compounds were added 15min prior to assay of iodide uptake in epithelial cells co-expressing F508-CFTR and a high sensitivity halide indicator (YFP-H148Q/I152L) in which F508-CFTR was targeted to the plasma membrane by culture at 27℃ for 24h. Thirty-two compounds with submicromolar activating potency were identified; most had tetrahydrobenzothiophene, benzofuran, pyramidinetrione, dihydropyridine, and anthraquinone core structures (360-480 daltons). Further screening of>1000 structural analogs revealed tetrahydrobenzothiophenes that activated F508-CFTR Cl- conductance reversibly with Kd<100nM. Single-cell voltage clamp analysis showed characteristic CFTR currents after F508-CFTR activation. Activation required low concentrations of a cAMP agonist, thus mimicking the normal physiological response. A Bayesian computational model was developed using tetrahydrobenzothiophene structure-activity data, yielding insight into the physical character and structural features of active and inactive potentiators and successfully predicting the activity of structural analogs. Efficient potentiation of defective F508-CFTR gating was also demonstrated in human bronchial epithelial cells from a F508 cystic fibrosis subject after 27℃ temperature rescue. In conjunction with correctors of defective F508-CFTR processing, small molecule potentiators of defective F508-CFTR gating may be useful for therapy of cystic fibrosis caused by the F508 mutation.